I’ve just published the Pocket Biotechnology Industry Primer and Glossary as an ebook. This book, which was previously only available as a printed book, is now available in digital format, which means greater convenience and a significant price reduction. This primer and glossary presents a broad, accessible, and comprehensive overview of the biotechnology industry and […]
The global locations of drug invention are important for public health, economic development, and national security reasons. Inventors tend to focus on diseases endemic to where they live. This is one of the problems of neglected diseases — there are few/no researchers working on certain diseases, which can lead to significant public health problems. Drugs […]
“What is the biggest challenge in moving a foreign biotechnology company to the United States?” I asked this question at the Delaware-New Jersey-Pennsylvania annual biotechnology conference and received a surprising response. The consensus was neatly stated by one of the panelists: “Moving to the US is like stealing in church.” For all the problems one […]
Thanks to a new sponsor, Breathing Additional Life into the Life Sciences is now free. The Journal of Commercial Biotechnology, published by thinkBiotech along with BiotechBlog, is proud to serve as a media sponsor for this upcoming conference on biotechnology development. Reaching the Next Milestone Conference on Breathing Additional Life into the Life Sciences Date: […]
What does selling bacon on the Internet have to do with biotechnology business development? Almost nothing! But, that is what makes this book so valuable. From Idea to Web Start-up in 21 Days: Creating bacn.com describes a shoestring venture to develop a simple web store. The founders decided to sell bacon due to the strong market […]
I’m back from the Filling the Pipeline conference in Boston, where I presented a talk on pharmaceutical globalization. Maintaining control of pharmaceutical drug innovation is key for national security, public health, and economic development. We know that much of late-stage development has gone overseas, but the question remains: Where are drugs invented? Using the DrugPatentWatch […]
NPR’s Moira Gunn recently interviewed Jeremy Abbate and I on the Scientific American Worldview project. Her interview, broadcast on Tech Nation, is now available at IT Conversations. For more details, you can also see our video interview and the Worldview website.
Off to Boston on Monday to give a talk on biotechnology globalization. I’ll post the slides when I return.
I often like to read books from technology-based companies outside of the biotechnology space because they can yield insights relevant to biotechnology business development. This book’s attention-grabbing title comes from the author’s experience working as a ranch hand prior to co-founding a computer hardware company. How to Castrate a Bull describes the growth of NetApp, […]
Drug Patent Expirations in October 2011 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ZOLINZA Merck vorinostat 6,087,367 Oct 4, 2011 ZORBTIVE Emd Serono somatropin recombinant 5,288,703 Oct 7, 2011 NUTRESTORE Emmaus Medcl glutamine 5,288,703 Oct 7, 2011 ATACAND Astrazeneca candesartan cilexetil 7,538,133*PED Oct 18, 2011 ATACAND HCT […]